Fenbendazole induces pyroptosis in breast cancer cells through HK2/caspase-3/GSDME signaling pathway. (2025)

Peer-Reviewed Study · Tingting Pan; Shengqi Jin; Xiaoxia Huang et al. · 2025

Tingting Pan et al., 2025: Pan et al. show fenbendazole kills mouse mammary carcinoma cells by pyroptosis through caspase-3/GSDME while suppressing hexokinase-2-dependent glycolysis, and reduces tumour growth in mice.

Mechanistically, FBZ activated the caspase – 3/GSDME pathway and inhibited HK2 – dependent glycolysis.

Tingting Pan et al., 2025: Pan et al. show fenbendazole kills mouse mammary carcinoma cells by pyroptosis through caspase-3/GSDME while suppressing hexokinase-2-dependent glycolysis, and reduces tumour growth in mice. Study type: mouse mammary carcinoma cells in vitro plus a mouse mammary carcinoma model in vivo. N: not stated in the abstract. Country: China. Dose: not stated in the abstract text captured. Funder: not stated in the record. Declared conflicts: 'The authors declare that the research was conducted in the absence of any commercial or financial relationships…'. Comparator: untreated cells and vehicle-treated mice. The typography of the abstract uses spaced hyphens ('caspase – 3'); the quotation preserves that.